Literature DB >> 6822401

Low ionic strength or chemical cross-linking of monomeric C3b increases its binding affinity to the human complement C3b receptor.

M A Arnaout, N Dana, J Melamed, R Medicus, H R Colten.   

Abstract

Quantitative studies of the interaction between a fragment of the third component of complement (C3b) and its receptor on human cells have been undertaken with a recently developed radioligand binding assay. Specific binding of fluid phase monomeric C3b was direct and saturable under low (mu = 0.0513) but not physiological (mu = 0.15) ionic strength. Dimeric C3b had a greater affinity for the C3b receptor at either ionic strength. Complexing of monomeric C3b with another protein (human IgG) did not result in increase in binding to human erythrocytes when compared with monomeric C3b alone. These data suggest that ionic forces are involved in C3b receptor-ligand interactions and that the stable C3b-receptor binding site is present in monomeric C3b. Furthermore they suggest that the greater affinity of dimeric or oligomeric C3b is a result of multimeric binding to preclustered C3b receptors. These findings provide an explanation for the relatively stable interaction of particle bound C3b and C3b receptor-bearing cells in the immune adherence reaction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6822401      PMCID: PMC1453915     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

2.  Use of dimethyl suberimidate, a cross-linking reagent, in studying the subunit structure of oligomeric proteins.

Authors:  G E Davies; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1970-07       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Binding of affinity cross-linked oligomers of IgG to cells bearing Fc receptors.

Authors:  D M Segal; E Hurwitz
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

5.  Ligand binding specificity of a rabbit alveolar macrophage receptor for C3b.

Authors:  R Dixit; R Schneider; S K Law; A Kulczycki; J P Atkinson
Journal:  J Biol Chem       Date:  1982-02-25       Impact factor: 5.157

6.  Interaction of particle-bound [125I]C3b, the third component of complement, with specific receptors on human B-lymphoblastoid cells (Raji).

Authors:  R Frade; J Strominger
Journal:  Immunol Lett       Date:  1981-08       Impact factor: 3.685

7.  Native and activated properdin: interconvertibility and identity of amino- and carboxy-terminal sequences.

Authors:  R G Medicus; A F Esser; H N Fernandez; H J Müller-Eberhard
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

8.  Third component of human complement: purification from plasma and physicochemical characterization.

Authors:  B D Tack; J W Prahl
Journal:  Biochemistry       Date:  1976-10-05       Impact factor: 3.162

9.  Specificity of human lymphocyte complement receptors.

Authors:  G D Ross; M J Polley
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

10.  Receptors for complement of leukocytes.

Authors:  W H Lay; V Nussenzweig
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  20 in total

1.  Influence of serotype of group B streptococci on C3 degradation.

Authors:  J R Campbell; C J Baker; M S Edwards
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

2.  Covalent binding of C3b to tetanus toxin: influence on uptake/internalization of antigen by antigen-specific and non-specific B cells.

Authors:  M B Villiers; C L Villiers; M R Jacquier-Sarlin; F M Gabert; A M Journet; M G Colomb
Journal:  Immunology       Date:  1996-11       Impact factor: 7.397

3.  Characteristics of iC3b binding to human polymorphonuclear leucocytes.

Authors:  D L Gordon; G M Johnson; M K Hostetter
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

4.  Immune adherence and staphylococcus protein A binding of soluble immune complexes produced by complement activation.

Authors:  J A Schifferli; D K Peters
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

5.  Complement-component-C3-opsonized immunoglobulin G anti-DNA antibodies do not bind effectively to red blood cells unless aggregated on a high-Mr DNA matrix.

Authors:  C Horgan; R P Taylor
Journal:  Biochem J       Date:  1984-12-15       Impact factor: 3.857

6.  Kinetic analysis of ex vivo human blood infection by Leishmania.

Authors:  Inmaculada Moreno; Mercedes Domínguez; Darío Cabañes; Carmen Aizpurua; Alfredo Toraño
Journal:  PLoS Negl Trop Dis       Date:  2010-07-13

7.  Increased expression of the C3b receptor by neutrophils and complement activation during haemodialysis.

Authors:  J Lee; R M Hakim; D T Fearon
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

8.  Lymphoblastoid cell supernatants increase expression of C3b receptors on human polymorphonuclear leucocytes: direct binding studies with 125I-C3b.

Authors:  M Berger; A S Cross
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

9.  C3b receptor (CR1) genomic polymorphism in rheumatoid arthritis. Low receptor levels on erythrocytes are an acquired phenomenon.

Authors:  A Kumar; A N Malaviya; S Sinha; P S Khandekar; K Banerjee; L M Srivastava
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

10.  Role of C3 in the control of monocyte C2 production.

Authors:  A O Hamilton; L Morrison; W S Kilpatrick; D Lappin; J C Bensa; D W Riches; K Whaley
Journal:  Immunology       Date:  1984-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.